https://ift.tt/2Ja72Ac
Submitted July 03, 2019 at 06:01PM by mvea https://ift.tt/32bKt5J
Wednesday, July 3, 2019
Researchers engineered a strain of non-pathogenic bacteria that colonize solid tumors and safely deliver immunotherapies, acting as a Trojan horse. The therapy led not only to complete tumor regression in a mouse model of lymphoma, but also significant control of distant, uninjected tumor lesions.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment